Scan to downloadSumitomo Pharma Co., Ltd. (4506) Earnings Releases & Disclosures
| Date | Type | Title | Files |
|---|---|---|---|
| 2026-10-30 | Earnings Release | Summary of Consolidated Financial Results for the Six Months Ended September 30, 2026 [IFRS] | |
| 2026-10-30 | Forecast Revision | Sumitomo Pharma Announces Variances Between H1 FY2026 Financial Forecasts and Actual Results and Revisions to FY2026 Financial Forecasts | |
| 2026-10-30 | Presentation Materials | Presentation Material (Conference on Q2 FY2026 Financial Results | |
| 2026-10-30 | Forecast Revision | Sumitomo Pharma Announces Revision of Its Year-End Dividend Forecast for the Fiscal Year Ending March 31, 2027 | |
| 2026-10-30 | — | Supplementary Financial Data (IFRS) for the Six Months Ended September 30, 2026 | |
| 2026-08-28 | Earnings Release | Notice Concerning Gain on Return of Retirement Benefit Trust (Extraordinary Income) Recorded in the Company’s Non-Consolidated Financial Statements | |
| 2026-08-12 | — | Regarding a Report Concerning Sumitomo Pharma (The Company's Views on the GCR August 7 Report) | |
| 2026-08-07 | — | Additional Explanation Regarding the Report “Sumitomo Chemical and Sumitomo Pharmaceutical: The 116 billion yen Swiss Shuffle” | |
| 2026-08-04 | — | Regarding a Report Concerning Sumitomo Pharma | |
| 2026-07-31 | Presentation Materials | Presentation Material (Conference on Q1 FY2026 Financial Results) | |
| 2026-07-31 | Earnings Release | Summary of Consolidated Financial Results for the Three Months Ended June 30, 2026 [IFRS] | |
| 2026-07-31 | — | Supplementary Financial Data (IFRS) for the Three Months Ended June 30, 2026 |
TDnet keeps only 31 days; this site accumulates daily and cannot backfill earlier disclosures.